Designing Personalized and Innovative Novel Drug Therapies for Cancer Treatment-Reference-Cited by-同舟云学术

Designing Personalized and Innovative Novel Drug Therapies for Cancer Treatment

Published:2020 Issue: Volume: Page:213-228
ISSN:
Container-title:Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
language:
Short-container-title:

Author:

Aggarwal Vaishali,Sak Katrin,Aggarwal Diwakar,Parashar Gaurav,Parashar Nidarshana Chaturvedi,Sood Shivani,Tuorkey Muobarak Jaber,Kaur Jagjit,Buttar Harpal Singh,Tuli Hardeep Singh

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-15-7586-0_11

Reference104 articles.

1. Tobore TO (2019) On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system. Future Sci OA 6(2):FSO439

2. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30

3. Aggarwal V, Banday AZ, Jindal AK, Das J, Rawat A (2020) Recent advances in elucidating the genetics of common variable immunodeficiency. Genes Dis 7(1):26–37

4. Aggarwal V, Das A, Bal A, Srinivasan R, Das R, Prakash G et al (2019) MYD88, CARD11, and CD79B oncogenic mutations are rare events in the indian cohort of de novo nodal diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol 27(4):311–318

5. Aggarwal V, Kashyap D, Sak K, Tuli HS, Jain A, Chaudhary A et al (2019) Molecular mechanisms of action of tocotrienols in cancer: recent trends and advancements. Int J Mol Sci 20(3):656

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic computational investigation to identify potential inhibitors against cancer by targeting P21-activated kinase 4 and D(CGATCG);Journal of Biomolecular Structure and Dynamics;2022-11-03

2. Immune Cell Metabolites as Fuel for Cancer Cells;Immuno-Oncology Crosstalk and Metabolism;2022